Literature DB >> 22585690

Adjuvant therapy for gastric cancer: revisiting the past to clarify the future.

Gabriel A Brooks, Peter C Enzinger, Charles S Fuchs.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22585690     DOI： 10.1200/JCO.2012.42.4069

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

1.  Survival in gastric cancer in relation to postoperative adjuvant therapy and determinants.

Authors:  Sevgi Ozden; Zerrin Ozgen; Hazan Ozyurt; Cengiz Gemici; Gokhan Yaprak; Huseyin Tepetam; Alpaslan Mayadagli
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

Review 2.  Mismatch Repair Deficiency and Response to Immune Checkpoint Blockade.

Authors:  Valerie Lee; Adrian Murphy; Dung T Le; Luis A Diaz
Journal:  Oncologist       Date:  2016-07-13

3.  Postoperative chemoradiotherapy versus postoperative chemotherapy for completely resected gastric cancer with D2 Lymphadenectomy: a meta-analysis.

Authors:  Yuan-Yuan Huang; Qiong Yang; Si-Wei Zhou; Ying Wei; Yan-Xian Chen; De-Rong Xie; Bei Zhang
Journal:  PLoS One       Date:  2013-07-18       Impact factor: 3.240

Review 4.  Perioperative therapy for locally advanced gastroesophageal cancer: current controversies and consensus of care.

Authors:  Amikar Sehdev; Daniel V T Catenacci
Journal:  J Hematol Oncol       Date:  2013-09-05       Impact factor: 17.388

5.  Chemoradiotherapy Is Inferior to Chemotherapy Alone in Adjuvant Setting for Signet Ring Cell Containing Gastric Cancer.

Authors:  Yue-Ting Zhu; Xin-Zu Chen; Ye Chen; Yu-Wen Zhou; Lian-Sha Tang; De-Yun Luo; Qiu Li; Meng Qiu; Xin Wang; Dan Cao; Yu Yang; Ya-Li Shen; Zhi-Ping Li; Feng Bi; Ji-Yan Liu; Hong-Feng Gou
Journal:  Front Oncol       Date:  2020-11-26       Impact factor: 6.244

Review 6.  Radiotherapy for tumors of the stomach and gastroesophageal junction--a review of its role in multimodal therapy.

Authors:  Daniel Buergy; Frank Lohr; Tobias Baack; Kerstin Siebenlist; Stefan Haneder; Henrik Michaely; Frederik Wenz; Judit Boda-Heggemann
Journal:  Radiat Oncol       Date:  2012-11-16       Impact factor: 3.481

Review 7.  Indirect comparison showed survival benefit from adjuvant chemoradiotherapy in completely resected gastric cancer with d2 lymphadenectomy.

Authors:  Qiong Yang; Ying Wei; Yan-Xian Chen; Si-Wei Zhou; Zhi-Min Jiang; De-Rong Xie
Journal:  Gastroenterol Res Pract       Date:  2013-10-01       Impact factor: 2.260

8.  The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer.

Authors:  Seong-Geun Kim; Sun-Hwi Hwang
Journal:  World J Surg Oncol       Date:  2016-04-02       Impact factor: 2.754

Review 9.  Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysis.

Authors:  Meng-Long Zhou; Mei Kang; Gui-Chao Li; Xiao-Mao Guo; Zhen Zhang
Journal:  World J Surg Oncol       Date:  2016-08-08       Impact factor: 2.754
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.